These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. O'Callaghan C; Milner AD; Swarbrick A Lancet; 1986 Dec 20-27; 2(8521-22):1424-5. PubMed ID: 2878277 [TBL] [Abstract][Full Text] [Related]
6. Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Lawford P; Jones BJ; Milledge JS Br Med J; 1978 Jan; 1(6105):84. PubMed ID: 339993 [No Abstract] [Full Text] [Related]
8. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Browne GJ; Penna AS; Phung X; Soo M Lancet; 1997 Feb; 349(9048):301-5. PubMed ID: 9024371 [TBL] [Abstract][Full Text] [Related]
9. Experiences with large doses of beta 2-agonists inhaled from nebulizers. Larsson S Postgrad Med J; 1983; 59 Suppl 3():71-2. PubMed ID: 6647211 [TBL] [Abstract][Full Text] [Related]
11. Hypokalaemia in children with asthma treated with nebulised salbutamol. Hartman S; Merkus P; Maseland M; Roovers L; van Setten P Arch Dis Child; 2015 Oct; 100(10):970-2. PubMed ID: 26044135 [No Abstract] [Full Text] [Related]
12. Children with asthma: will nebulised salbutamol reduce hospital admissions? Osborne JP; Cocksedge S Br Med J (Clin Res Ed); 1985 Apr; 290(6474):1076-7. PubMed ID: 3921114 [No Abstract] [Full Text] [Related]
13. Children with asthma: will nebulised salbutamol reduce hospital admissions? Pearce JL; Wesley HM Br Med J (Clin Res Ed); 1985 Feb; 290(6468):595-7. PubMed ID: 3918686 [TBL] [Abstract][Full Text] [Related]
14. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. Baronti A; Grieco A; Vibelli C Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574 [TBL] [Abstract][Full Text] [Related]
15. Worldwide experience with albuterol (salbutamol). Godfrey S Ann Allergy; 1981 Nov; 47(5 Pt 2):423-6. PubMed ID: 7305084 [No Abstract] [Full Text] [Related]
16. Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics. Larsson S; Svedmyr N Am Rev Respir Dis; 1977 Nov; 116(5):861-9. PubMed ID: 921062 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of nebulised and inhaled salbutamol on breathlessness in severe COPD. Poole PJ; Saini R; Brodie SM; Black PN Respir Med; 2005 Mar; 99(3):372-6. PubMed ID: 15733514 [TBL] [Abstract][Full Text] [Related]
18. Salbutamol by intermittent positive pressure ventilation in status asthmaticus. Choo-Kang YF; Tribe AE; Grant IW Scott Med J; 1974 Jul; 19(4):191-5. PubMed ID: 4134936 [No Abstract] [Full Text] [Related]
19. [Intravenous salbutamol in the treatment of bronchial spasm]. Mariotta S; Pasqua F; Mannino F Minerva Med; 1978 Jan; 69(4):257-60. PubMed ID: 342989 [TBL] [Abstract][Full Text] [Related]
20. Association between inhaler use and risk of haemoptysis in patients with non-cystic fibrosis bronchiectasis. Jang EJ; Lee CH; Yoon HI; Kim YJ; Kim JM; Choi SM; Yim JJ; Kim DK Respirology; 2015 Nov; 20(8):1213-21. PubMed ID: 26293490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]